These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6448605)

  • 41. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
    Delmas PD; Chapuy MC; Meunier PJ
    Horm Metab Res; 1984 May; 16(5):258-61. PubMed ID: 6234216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental basis for the clinical use of diphosphonates in Paget's disease of bone.
    Fleisch H
    Arthritis Rheum; 1980 Oct; 23(10):1162-71. PubMed ID: 6252908
    [No Abstract]   [Full Text] [Related]  

  • 43. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
    Chapuy MC; Charhon SA; Meunier PJ
    Metab Bone Dis Relat Res; 1983; 4(6):325-8. PubMed ID: 6229683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
    Rendina D; Mossetti G; Viceconti R; Sorrentino M; Nunziata V
    Calcif Tissue Int; 2004 Sep; 75(3):189-96. PubMed ID: 15148558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
    D'Amore M; Carrozzo M; Cantatore FP; Scagliusi P; Pipitone V
    Panminerva Med; 1984; 26(1):13-7. PubMed ID: 6233523
    [No Abstract]   [Full Text] [Related]  

  • 46. Paget's disease of bone: diagnosis and management.
    Kanis JA; Evanson JM; Russell RG
    Metab Bone Dis Relat Res; 1981; 3(4-5):219-30. PubMed ID: 6220190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Etidronic acid therapy in Paget's disease of bone].
    Holz G; Delling G; Ziegler R
    Dtsch Med Wochenschr; 1983 Dec; 108(51-52):1954-8. PubMed ID: 6418505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
    Douglas DL; Duckworth T; Russell RG; Kanis JA; Preston CJ; Preston FE; Prenton MA; Woodhead JS
    Lancet; 1980 May; 1(8177):1043-7. PubMed ID: 6103389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of Paget's disease of bone with bisphosphonates.
    Mazières B
    Rev Rhum Engl Ed; 1995 Feb; 62(2):72-8. PubMed ID: 7600075
    [No Abstract]   [Full Text] [Related]  

  • 50. Paget's disease of bone.
    Ryan WG
    Annu Rev Med; 1977; 28():143-52. PubMed ID: 140620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Paget's disease of bone.
    Melick RA
    Med J Aust; 1985 Oct; 143(9):394-7. PubMed ID: 2932626
    [No Abstract]   [Full Text] [Related]  

  • 52. Efficacy of the bisphosphonate APD in the control of Paget's bone disease.
    Mautalen CA; Gonzalez D; Ghiringhelli G
    Bone; 1985; 6(6):429-32. PubMed ID: 4096879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determinants of remission of Paget's disease of bone.
    Patel S; Stone MD; Coupland C; Hosking DJ
    J Bone Miner Res; 1993 Dec; 8(12):1467-73. PubMed ID: 8304048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcitonin or EHDP in Paget's disease?
    Bijvoet OL; Hosking DJ; Van Aken J; Will EJ
    Calcif Tissue Res; 1977 May; 22 Suppl():494. PubMed ID: 410489
    [No Abstract]   [Full Text] [Related]  

  • 55. Procollagen-III peptide serum levels in Paget's disease of the bone.
    Wilder-Smith CH; Raue F; Holz-Gottswinter G; Ziegler R
    Klin Wochenschr; 1987 Feb; 65(4):174-8. PubMed ID: 3104661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.
    Yates AJ; Percival RC; Gray RE; Atkins RM; Urwin GH; Hamdy NA; Preston CJ; Beneton MN; Russell RG; Kanis JA
    Lancet; 1985 Jun; 1(8444):1474-7. PubMed ID: 2861411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of intravenous pamidronate therapy on Paget's disease of bone.
    Bombassei GJ; Yocono M; Raisz LG
    Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Etidronate disodium in the treatment of Paget's disease of bone.
    Krane SM
    Ann Intern Med; 1982 May; 96(5):619-25. PubMed ID: 6280538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study].
    Eisinger J; Laponche AM; Ouaniche J
    Rev Rhum Mal Osteoartic; 1986 Mar; 53(3):183-5. PubMed ID: 3085204
    [No Abstract]   [Full Text] [Related]  

  • 60. Paget's disease of bone: assessment and management.
    Ibbertson HK; Fraser TR; Scott DJ; Cullen JC; Henley JW; Stephens ES; Tait B; Wattie DJ
    Drugs; 1979 Jul; 18(1):33-47. PubMed ID: 157870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.